Showing results (171-180 of 215) with videos related to
Sort By:
Pageof 22
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 15, 2005
The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinomaOla Nada, Mohamed Abdel-Hamid, Alaa Ismail, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 23, 2018
Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian ExperienceMohamed El Kassas, Dalia Omran, Kadry Elsaeed, et al.European Journal of Gastroenterology & Hepatology|October 28, 2009
Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1Abdel-Rahman N Zekri, Rabab A N Moharram, Waleed S Mohamed, et al.Immunological Investigations|October 17, 2019
Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV PatientsMustafa Neamatallah, Mahmoud El-Bendary, Hatem Elalfy, et al.International Journal of STD & AIDS|November 17, 2025
Prevalence and clinical characteristics of individuals presenting with AIDS and late HIV diagnosis in EgyptLamiaa Al Sehemy, Rahma Mohamed, Ammar Hatem, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2026
Diagnostic Performance of Fatty Liver Index for Hepatic Steatosis and its Association With Fibrosis in People Living With HIVAhmed Cordie, Ahmed M Kamel, Rahma Mohamed, et al.Hepatology (Baltimore, Md.)|January 13, 2015
How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countriesDorothée Obach, Yazdan Yazdanpanah, Gamal Esmat, et al.Expert Review of Endocrinology & Metabolism|July 3, 2026
Resmetirom and semaglutide therapy for patients with MAFLD in the MENA region: expert panel recommendationsYasser Fouad, Khalid M AlNaamani, Fatheya Alawadi, et al.Plos One|September 23, 2021
Predictors of severity and development of critical illness of Egyptian COVID-19 patients: A multicenter studyDalia Omran, Mohamed Al Soda, Eshak Bahbah, et al.Journal of Hepatology|February 24, 2007
Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis CGamal Esmat, Mohamed Metwally, Khalid R Zalata, et al.Pageof 22